Concept information
Preferred term
Novartis Group
Definition(s)
- NOVARTIS GROUP (SWITZERLAND) is involved in research, development, manufacturing, and marketing of original and generic healthcare products. Several antineoplastic agents are among Novartis' top-selling pharmaceuticals, including Gleevec/Glivec (imatinib mesylate), used in chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors, with possible application in other types of cancer; Zometa (zoledronic acid), used in hypercalcemia of malignancy, multiple myeloma, and bone metastases; Sandostatin/Sandostatin LAR (octreotide acetate), used in acromegaly and gastroenteropancreatic neuroendocrine tumors; and Femara (letrozole), used in estrogen-receptor-positive breast cancer. [Source: Encyclopedia of Cancer and Society; Novartis Group]
Broader concept(s)
Belongs to group
URI
http://data.loterre.fr/ark:/67375/N9J-KT2HD7C0-D
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}